I am more convinced than ever that we are on the right track.
HOMEWORK,HOMEWORK,HOMEWORK
This was posted this morning:
Posted 27 minutes ago 3/12/2009 9:00 am
by Teri
I was told yesterday that the "Til Harvest" that MDA,(MD Anderson) is doing is seeing more response (positive) to patients that have had IL-2 prior to using their T-cell harvested cells. They told me currently there is a 36 year old female patient being treated and she is almost NED....she had lung lesions, did IL-2, and now is doing T-cell.
You're much more technical than I am, but I think that goes along w/ your hypothesis....the cells were pre-activated and then more responsive when the T-cells were used.
Well done my faithful servant!
Teri2007
=================================================================
Medarex, Inc. Manufacturer of the monoclonal antibodies
Dear Mr. Breitfeller:
Thank you for your email. It has been forwarded to our clinical development team.
We are continuing to develop Ipilimumab with Bristol-Myers Squibb and studies are ongoing.
Your interest is appreciated.
Best Regards,
Alicia Allen
Assistant to Christian Schade
Senior Vice President &
Chief Financial Officer
Medarex, Inc.
No comments:
Post a Comment